In today’s recent session, 1.48 million shares of the TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) have been traded, and its beta is -0.08. Most recently the company’s share price was $1.80, and it changed around -$0.14 or -7.22% from the last close, which brings the market valuation of the company to $0.05M. TCBP at last check was trading at a discount to its 52-week high of $523.20, offering almost -28966.67% off that amount. The share price’s 52-week low was $1.75, which indicates that the recent value has risen by an impressive 2.78% since then.

TC BioPharm (Holdings) plc ADR stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended TCBP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. TC BioPharm (Holdings) plc ADR is expected to report earnings per share of 0 for the current quarter.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information

Instantly TCBP has been showing red trend so far today with a performance of -7.22% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.3246 on recent trading dayincreased the stock’s daily price by 22.57%. The company’s shares are currently down -82.56% year-to-date, but still down -13.46% over the last five days. On the other hand, TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) is -71.47% down in the 30-day period.

TC BioPharm (Holdings) plc ADR (TCBP) estimates and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 45.82%.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders

The former held 19.07 shares worth $33958.0, making up 0.05% of all outstanding shares.